Cargando…

Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis

BACKGROUND: With a suite of promising new RSV prophylactics on the horizon, including long-acting monoclonal antibodies and new vaccines, it is likely that one or more of these will replace the current monoclonal Palivizumab programme. However, choosing the optimal intervention programme will requir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodgson, David, Pebody, Richard, Panovska-Griffiths, Jasmina, Baguelin, Marc, Atkins, Katherine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672821/ https://www.ncbi.nlm.nih.gov/pubmed/33203423 http://dx.doi.org/10.1186/s12916-020-01802-8

Ejemplares similares

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis
por: Hodgson, David, et al.
Publicado: (2017)

Estimates for quality of life loss due to Respiratory Syncytial Virus
por: Hodgson, David, et al.
Publicado: (2019)

Can mathematical modelling solve the current Covid-19 crisis?
por: Panovska-Griffiths, Jasmina
Publicado: (2020)

A6 Does treatment cause virulence changes in HIV-1?
por: Hodgson, David, et al.
Publicado: (2019)

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
por: Thorrington, Dominic, et al.
Publicado: (2017)

A gene regulatory motif that generates oscillatory or multiway switch outputs
por: Panovska-Griffiths, Jasmina, et al.
Publicado: (2013)

A method for evaluating the cost-benefit of different preparedness planning policies against pandemic influenza
por: Panovska-Griffiths, Jasmina, et al.
Publicado: (2020)

Jasmina Panovska‐Griffiths' discussion contribution to papers in Session 3 of the Royal Statistical Society's special topic meeting on COVID‐19 transmission: 11 June 2021
por: Panovska‐Griffiths, Jasmina
Publicado: (2022)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis
por: Sandmann, Frank G., et al.
Publicado: (2022)

Strategies for active and passive pediatric RSV immunization
por: Eichinger, Katherine M., et al.
Publicado: (2021)

Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England
por: Sharp, Ashley, et al.
Publicado: (2021)

fluEvidenceSynthesis: An R package for evidence synthesis based analysis of epidemiological outbreaks
por: van Leeuwen, Edwin, et al.
Publicado: (2017)

Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis
por: Laufer, Rachel S., et al.
Publicado: (2023)

Tracking the national and regional COVID-19 epidemic status in the UK using weighted principal component analysis
por: Swallow, Ben, et al.
Publicado: (2022)

Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study
por: Panovska-Griffiths, Jasmina, et al.
Publicado: (2020)

Unpacking the Black Box of Implementation: The Next Generation for Policy, Research and Practice
por: Hoagwood, Kimberly, et al.
Publicado: (2013)

Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot
por: Atkins, Katherine, et al.
Publicado: (2016)

What RSV interventions are in the research pipeline?
por: Duong, Diana
Publicado: (2023)

Mathematical modeling for COVID-19 with focus on intervention strategies and cost-effectiveness analysis
por: Deng, Yang, et al.
Publicado: (2022)

Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor
por: Leber, Werner, et al.
Publicado: (2021)

Using probabilistically linked data to investigate the burden of Respiratory Syncytial Virus (RSV) in children <5 years of age on secondary care in England
por: Reeves, Rachel, et al.
Publicado: (2017)

Mathematical modeling as a tool for policy decision making: Applications to the COVID-19 pandemic
por: Panovska-Griffiths, J., et al.
Publicado: (2021)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling
por: Opatowski, Lulla, et al.
Publicado: (2018)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
por: Bentley, Anthony, et al.
Publicado: (2013)

The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations
por: Siakallis, Loizos, et al.
Publicado: (2023)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Gatt, Dvir, et al.
Publicado: (2023)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study
por: Do, Lien Anh Ha, et al.
Publicado: (2023)

A novel approach to evaluating the UK childhood immunisation schedule: estimating the effective coverage vector across the entire vaccine programme
por: Crowe, Sonya, et al.
Publicado: (2015)

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
por: Li, Xiao, et al.
Publicado: (2020)

Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007‐2012
por: Reeves, Rachel Melanie, et al.
Publicado: (2017)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age Groups
por: Rafferty, Ellen, et al.
Publicado: (2022)

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
por: Guerra-Maupome, Mariana, et al.
Publicado: (2019)

Testing, tracing and isolation in compartmental models
por: Sturniolo, Simone, et al.
Publicado: (2021)

Impact of national-scale targeted point-of-care symptomatic lateral flow testing on trends in COVID-19 infections, hospitalisations and deaths during the second epidemic wave in Austria (REAP3)
por: Reitzinger, Stephanie, et al.
Publicado: (2023)

Next Generation Business Strategies for the Base of the Pyramid
por: London, Ted
Publicado: (2010)

Next-Generation Technologies and Strategies for the Management of Retinoblastoma
por: Gudiseva, Harini V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ric79u8v8e516qame8gg9kcc3m